TARDBP and amyotrophic lateral sclerosis: As ALS patients with SOD1 mutations also lack TDP-43 pathology [315,316], this raised the possibility that various pathways for mitochondrial removal are activated in MNs, each potentially playing a distinct role in ALS development.